APOBEC3B and B-cell non-Hodgkin lymphoma: In comparison, recent studies showed that human A3B driven tumors in mice (hepatocellular carcinomas and B cell lymphomas) exhibit an opposite APOBEC3 mutation signature bias with 53% YTCW and 47% RTCW [72].